SETD2 and neoplasm: In parallel, each region was scored by H&E pathologic analysis of key tumor features such as grade, stage, and necrosis, and IHC was used to assess levels of H3K36me3 (the mark written by the SETD2 histone methyltransferase), and DNA methylation (5mC).